切换至 "中华医学电子期刊资源库"

中华卫生应急电子杂志 ›› 2020, Vol. 06 ›› Issue (01) : 23 -27. doi: 10.3877/cma.j.issn.2095-9133.2020.01.004

所属专题: 文献

论著

丙型肝炎肝硬化患者单核细胞促炎因子与抑炎因子的表达
张永萍1,(), 刘兰1, 张艳君2   
  1. 1. 830000 新疆乌鲁木齐,新疆维吾尔自治区人民医院感染科
    2. 临床医学研究中心
  • 收稿日期:2019-06-24 出版日期:2020-02-18
  • 通信作者: 张永萍
  • 基金资助:
    新疆维吾尔自治区自然科学基金(2015211C207)

Expression of monocytes pro-inflammatory cytokines and anti-inflammatory factors in patients with hepatitisC cirrhosis

Yongping Zhang1,(), Lan Liu1, Yanjun Zhang2   

  1. 1. Department of Infectious Diseases, Xinjiang Autonomous Region People’s Hospital, Urumqi, 830000, China
    2. Clinical Medical Research Center, Xinjiang Autonomous Region People’s Hospital, Urumqi, 830000, China
  • Received:2019-06-24 Published:2020-02-18
  • Corresponding author: Yongping Zhang
  • About author:
    Corresponding author: Zhang Yongping, Email:
引用本文:

张永萍, 刘兰, 张艳君. 丙型肝炎肝硬化患者单核细胞促炎因子与抑炎因子的表达[J]. 中华卫生应急电子杂志, 2020, 06(01): 23-27.

Yongping Zhang, Lan Liu, Yanjun Zhang. Expression of monocytes pro-inflammatory cytokines and anti-inflammatory factors in patients with hepatitisC cirrhosis[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2020, 06(01): 23-27.

目的

了解丙肝肝硬化患者单核细胞促炎因子与抑炎因子的表达。

方法

选取2016年1月至2017年5月因丙肝肝硬化入住新疆维吾尔自治区人民医院感染内科的35例患者为丙肝组,健康体检者18例为对照组。常规检测两组患者生化、血脂、血常规等基线资料,提取外周血单核细胞予以培养并提取DNA,测定TNF-α、IL1-β、IL-12-β、IL-10、TGF-β和IL-4 mRNA转录水平及病例组血清HCV-RNA载量。

结果

丙肝组中ALT、AST和TG水平高于对照组,差异有统计学意义(P<0.05);丙肝组中ALB、WBC和PLT低于对照组,差异有统计学意义(P<0.05)。两组患者的TNF-α、IL1-β、IL-12β和IL-4水平无统计学意义(P>0.05),IL-10和TGF-β的表达有统计学意义(P<0.05)。HCV-RNA载量与TNF-α、IL-12β呈正相关(r=0.452,0.442;P<0.05),与IL-10和TGF-β呈负相关(r=-0.431,-0.437,P<0.05)。丙肝组TNF-α与IL1-β、IL-12-β表达呈正相关(r=0.531,0.766,0.448,P<0.05),TNF-α与IL-10、TGF-β呈负相关(r=-0.732,-0.749,P<0.05);IL1-β与IL-10、TGF-β呈负相关(r=-0.438,-0.448,P<0.05);IL-12-β与IL-10、TGF-β呈负相关(r=-0.996,-0.999,P<0.05)。IL-10和TGF-β的表达呈正相关(r=0.999,P<0.05)。

结论

丙肝肝硬化患者单核细胞高表达IL-10和TGF-β。

Objective

To study the expression of monocytes pro-inflammatory cytokines and anti-inflammatory factors in patients with hepatitis C cirrhosis.

Methods

A total of 35 patients with hepatitis C virus-associated cirrhosis were collected from January 2016 to May 2017 in infection department of our hospital. 18 health subjects were enrolled in as control group. Biochemical index, blood lipids, blood routine and other baseline data were detected.

Results

The level of ALT, AST and triglyceride were higher than those of control group, the differences were statistically significant (P<0.05); Albumin, white blood cells and platelet count were lower than those of control group, the differences were statistically significant (P<0.05). The expression of TNF-α, IL1-β, IL-12β and IL-4 was similar in patients group and control group (P>0.05). However, IL-10 and TGF-β expressed in both groups were statistically significant (P<0.05). The HCV-RNA load in patient group was positively correlated with TNF-α, IL-12β (r= 0.452, 0.442, respectively, P<0.05) and negatively correlated with IL-10 and TGF-β (r=-0.732, -0.749, P>0.05). IL-1β and IL-4 displayed no relation with HCV-RNA load. TNF-α displayed a positive correlation with IL1-β and IL-12-β in patient group(r=0.531, 0.7660, 0.448, respectively, P<0.05), TNF-α negatively correlated with IL-10 and TGF-β (r=-0.732, -0.749, respectively, P<0.05). IL-12β also negatively correlated with IL-10 and TGF-β (r=-0.996, -0.999, P<0.05). IL-10 showed a positive correlation with TGF-β cytokines (r=0.999, P<0.05).

Conclusions

IL-10 and TGF-β are highly expressed in monocytes of patients with hepatitis C cirrhosis.

表1 两组基本临床资料比较(±s)
表2 两组细胞因子表达比较(±s)
表3 HCV-RNA载量与细胞因子的偏相关分析
表4 丙肝组中细胞因子间相关分析
[1]
Guo H,Callaway JB,Ting JP.Inflammasomes: mechanism of action, role in disease, and therapeutics[J].Nat Med,2015,21(7):677-687.
[2]
Park SH,Shin EC.Direct ex vivo functional analysis of HCV-specific t cells[J].Methods Mol Biol,2019,1911:349-361.
[3]
Estevez J,Chen VL,Podlaha O,et al.Differential serum cytokine profiles in patients with chronic hepatitis b,c,and hepatocellular carcinoma[J].Sci Rep,2017,7(1):11867.
[4]
Yang R,Gao N,Chang Q,et al.The role of IDO,IL-10, and TGF-beta in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma[J].J Med Virol,2019,91(2):265-271.
[5]
中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2015更新版)[J].中华临床感染病杂志,2015,8(6):504-525.
[6]
Pang X,Wang Z,Zhai N,et al.IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acid[J].Int Immunopharmacol,2016,38:284-290.
[7]
Niesen E,Schmidt J,Flecken T,et al.Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells[J].J Infect Dis,2015,211(5):821-826.
[8]
Liu BS,Groothuismink ZM,Janssen HL,et al.Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections[J].J Leukoc Biol,2011,89(6):981-988.
[9]
Couper KN,Blount DG,Riley EM.IL-10: the master regulator of immunity to infection[J].J Immunol,2008,180(9):5771-5777.
[10]
Flynn JK,Dore GJ,Hellard M,et al.Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users[J].J Viral Hepat,2011,18(8):549-561.
[11]
Antoniades CG,Wendon J,Vergani D.Paralysed monocytes in acute on chronic liver disease[J].J Hepatol,2005,42(2):163-165.
[12]
Fabregat I,Caballero-Díaz D.Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis[J].Frontiers in Oncology,2018,8:357.
[13]
Verma V,Chakravarti A,Kar P.Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease[J].Dig Dis Sci,2008,53(8):2233-2237.
[14]
Fabregat I,Moreno-Caceres J,Sanchez A,et al.TGF-beta signalling and liver disease[J].FEBS J,2016,283(12):2219-2232.
[15]
Sheng J,Chen W,Zhu HJ.The immune suppressive function of transforming growth factor-beta(TGF-beta)in human diseases[J].Growth Factors,2015,33(2):92-101.
[16]
Martinez-Esparza M,Tristan-Manzano M,Ruiz-Alcaraz AJ,et al.Inflammatory status in human hepatic cirrhosis[J].World J Gastroenterol,2015,21(41):11522-11541.
[17]
Segura-Cerda CA,Aceves-Sanchez MJ,Perez-Koldenkova V,et al.Macrophage infection with combinations of BCG mutants reduces induction of TNF-alpha, IL-6, IL-1beta and increases IL-4[J].Tuberculosis (Edinb),2019,115:42-48.
[18]
Waqas S,Ampem G,Roszer T.Analysis of IL-4/STAT6 Signaling in Macrophages[J].Methods Mol Biol,2019,1966:211-224.
[19]
Zhao J,Jiang L,Deng L,et al.Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4 Ralpha therapeutic antibody[J].MAbs,2019:11(5):837-847.
[20]
Impellizzieri D,Ridder F,Raeber ME,et al.IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation[J].J Allergy Clin Immunol,2019,144(1):267-279.
[21]
Boccardi V,Westman E,Pelini L,et al.Differential associations of IL-4 with hippocampal subfields in mild cognitive impairment and alzheimer's disease[J].Front Aging Neurosci,2019,10:439.
[22]
Carneros D,Santamaria EM,Larequi E,et al.Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization[J].FASEB J,2019,33(6):7578-7587.
[23]
Hao G,Duan W,Sun J,et al.Effects of febuxostat on serum cytokines IL-1,IL-4,IL-6, IL-8, TNF-alpha and COX-2[J].Exp Ther Med,2019,17(1):812-816.
[24]
Ha JW,You MJ,Park HS,et al.Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation[J].Arch Pharm Res,2019,42(4):359-368.
[1] 娄丽丽, 刘瀚旻. 儿童狼疮性肾炎相关肾小管间质损伤的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 373-378.
[2] 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[5] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[6] 李芳, 孙海云. 风险因素护理干预对合并失代偿性肝硬化的腹股沟疝患者Lichtenstein术围手术期应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 477-480.
[7] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[8] 李勇, 兰川, 吴斌, 张光年, 李敬东. 术前血小板-白蛋白评分对肝硬化肝癌术后预后的预测价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 412-416.
[9] 许语阳, 吕云福, 王葆春. 乙肝后肝硬化门静脉高压症脾肿大外科治疗进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 469-473.
[10] 秦维, 王丹, 孙玉, 霍玉玲, 祝素平, 郑艳丽, 薛瑞. 血清层粘连蛋白、Ⅳ型胶原蛋白对代偿期肝硬化食管胃静脉曲张出血的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 447-451.
[11] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[12] 朱翔宇, 王建美, 张辉, 叶红英. 无创左心室压力-应变循环技术在左心室功能参数与肝硬化的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 494-498.
[13] 郭亮亮, 邱珊珊, 钟萍, 赵心恺. 血小板-白蛋白-胆红素评分对肝硬化上消化道出血的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 216-219.
[14] 刘立业, 赵德芳. 非酒精性脂肪肝患者血清细胞因子信号转导抑制因子3、肝X受体α水平与CT影像学特征的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 211-215.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要